N4 Pharma appoints David Solomon as CEO
The company is to be renamed Thalia Therapeutics to reflect its strategic transition
Read MoreAppointments and people articles
Mar 2, 2026 | Appointments
The company is to be renamed Thalia Therapeutics to reflect its strategic transition
Read MoreFeb 19, 2026 | Appointments
Sial has authored multiple peer-reviewed publications for major journals
Read MoreFeb 17, 2026 | Appointments
Veys has served at THX for almost a decade, including as Chief Operating Officer
Read MoreFeb 11, 2026 | Appointments
McDonagh has held senior leadership positions at Roche, Medtronic, Cellnovo and Insulet
Read MoreFeb 10, 2026 | Appointments
Zuideveld was most recently CEO of Versameb, and has held senior roles at Caris Life Sciences and Roche
Read MoreFeb 9, 2026 | Appointments
DeSimone was formerly President of US Oncology at Merck
Read MoreFeb 6, 2026 | Appointments
Tansey Chevlen previously spent over 17 years at Amgen in multiple leadership roles
Read MoreJan 29, 2026 | Appointments
Haviland was most recently President and CEO of Blueprint Medicines
Read MoreJan 28, 2026 | Appointments
Lefranc has served at Ipsen since 2013, most recently as Senior Vice President
Read MoreJan 27, 2026 | Appointments
Terri and Mark both have extensive life sciences and consulting experience
Read MoreJan 23, 2026 | Appointments
Ryan’s most recent role was Executive VP and US Head of Digital & Innovation at GCI Health
Read MoreJan 16, 2026 | Appointments
Lee previously held senior roles at ImmPACT Bio, Neogene Therapeutics and AstraZeneca
Read More
